Plasma Exchange Shows Promise for Deadly Mushroom Poisoning Treatment

Amatoxin poisoning from deadly mushrooms like Amanita phalloides causes severe liver failure with mortality rates reaching 10-30%. Current treatment relies mainly on supportive care, as no specific antidote exists. This multi-center European study examined whether therapeutic plasma exchange (TPE) could improve outcomes in severe cases.

Researchers analyzed 102 patients with confirmed amatoxin poisoning across 24 centers from 2010-2023. Patients were divided into those receiving TPE plus standard care versus standard care alone. The primary outcome was 21-day transplant-free survival.

Key results showed TPE was associated with improved survival when initiated within 48 hours of symptom onset. Patients receiving early TPE had better liver function recovery and reduced need for liver transplantation. The benefit was most pronounced in those with acute liver failure, where TPE appeared to remove circulating toxins and inflammatory mediators.

The study suggests TPE may offer a valuable treatment option for severe amatoxin poisoning, particularly when started early. However, the observational design means causation cannot be definitively established. The findings support developing standardized protocols for TPE use in mushroom poisoning cases.

This research addresses a critical gap in treating one of the most dangerous forms of food poisoning, potentially saving lives in cases where liver transplantation isn't immediately available.